4 Pyrrolnitrinの全合成
スポンサーリンク
概要
- 論文の詳細を見る
Total synthesis of Pyrrolnitrin (I), an antibiotic from Pseudomonas pyrocinia, was achieved by several different routes. At first, a key intermediate (IIIa) was prepared by the introduction of a methyl group to the α-position of the pyrrole (Va), Paal Knorr condensation of the 2,5-hexanedione (XII) and the introduction of two methyl groups to the pyrrole (XIV). The second type of key intermediates, β-aryl-5-methyl-2-pyrrolecarboxylic esters (XXXI and II), were synthesized from pyrroles, XIV, XXIII and XX, mainly by the methylation or methoxycarbonylation to the α-position. And the third type of key intermediates, 3-aryl-2,5-pyrroledicarboxylic esters, XXVIa, b, d, were synthesized by the introduction of the ethoxycarbonyl group to the pyrrole (XX), and by the condensation of the arylglyoxals (XXIVb, d) with dimethyl acetyliminodiacetate (XXV). The α,α'-disubstituted-3-arylpyrroles, IIIa, XXI and XXVIa, thus prepared, were transformed to Pyrrolnitrin (I) by chlorination with SO_2Cl_2, hydrolysis and decayboxylation. It was also found that 3-arylpyrrolecarboxylic esters, XLI, XLV, XXXIXa, XLVII and XLVI, were transformed directly to I by the treatment with conc. H_2SO_4. And in the course of the synthetic research, a new method of pyrrole ringclosure was developed: nitro-chlorophenylpyruvates (VIIIa and XVIII) and the nitro-chlorophenylacetone (Xa) were condensed with aminoacetal (XIII) to give pyrroles, XIV, XX and XXIII. And Hantzsch reaction was extended also to give the pyrrole (XIV).
- 天然有機化合物討論会の論文
- 1968-09-20
著者
-
田中 邦彦
Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
海尾 澄則
藤沢薬品中央研究所
-
刈米 和夫
藤沢薬品中央研究所
-
田中 邦彦
藤沢薬品中央研究所
-
植田 育男
藤沢薬品中央研究所
-
田中 邦彦
Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
植田 育男
Central Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
海尾 澄則
Fujisawa Pharmaceutical Co. Ltd.
関連論文
- Total Synthesis of Pyrrolnitrin. II. Synthesis of Ethyl 3-Aryl-5-methyl-2-pyrrolecarboxylate. (1)
- Pyrrolnitrinの全合成
- 1.Pyrrolnitrinの全合成並びにその類似化合物の合成
- Total Synthesis of Pyrrolnitrin. V. Synthesis of Pyrrolnitrin and Its Analogues. (1)
- New 2-Aryliminoimidazolidines. I. Synthesis and Antihypertensive Properties of 2-(2-Phenoxyphenylimino) imidazolidines and Related Compounds
- Neurotropic and Psychotropic Agents. VII. Synthesis and Pharmacological Properties of 2-(Alkoxyalkylamino)-3H-1,4-benzodiazepines
- Neurotropic and Psychotropic Agents. V. An Improved Synthesis of 7-Chloro-5-(2-chlorophenyl)-2-(2-dimethylaminoethylthio)-3H-1,4-benzodiazepine and Related Compounds
- Neurotropic and Psychotropic Agents. IV. Synthesis and Pharmacological Properties of 7-Chloro-5-(2-chlorophenyl)-2-(2-dimethylaminoethylthio)-3H-1,4-benzodiazepine and Related Compounds
- Neurotropic and Psychotropic Agents. VI. 1-Alkoxymethyl-1,3-dihydro-2H-1,4-benzodiazepin-2-ones
- Synthesis and Pharmacological Properties of 8-Chloro-10-(2-dimethylaminoethoxy) dibenzo [b, f] thiepin and Related Compounds. Neurotropic and Psychotropic Agents. III
- The Synthesis of 10-(4-Methylpiperazino) dibenzo [b, f] thiepin and Related Compounds. Neurotropic and Psychotropic Agents
- Structure-Activity Studies of Pyrrolnitrin Analogues
- Total Synthesis of Pyrrolnitrin. X. Synthesis of Pyrrolnitrin. (2)
- Total Synthesis of Pyrrolnitrin. IX. Synthesis of Dialkyl 3-Aryl-2,5-pyrroledicarboxylates and Alkyl β-Aryl-5-methyl-2-pyrrolecarboxylates
- Total Synthesis of Pyrrolnitrin. VIII. A New Method of Pyrrole Ringclosure using Aminoacetal
- Total Synthesis of Pyrrolnitrin. VII. Synthesis of 2,5-Dimethyl-3-arylpyrrole
- Total Synthesis of Pyrrolnitrin. VI. Synthesis of Nitro-chloro-2-aminoacetophenones and 1-Aryl-1,3-butanediones
- Total Synthesis of Pyrrolnitrin. IV. Synthesis of Ethyl 3-Aryl-5-methyl-2-pyrrolecarboxylate. (3)
- Total Synthesis of Pyrrolnitrin. III. Synthesis of Ethyl 3-Aryl-5-methyl-2-pyrrolecarboxylate. (2)
- Total Synthesis of Pyrrolnitrin. I. Synthesis of 3-Arylpyrrole Derivatives by Knorr's Condensation
- 4 Pyrrolnitrinの全合成
- Synthesis of DL-Thiamic Acid
- Studies on the Synthesis of 17β-Hydroxyandrostan-3-one